VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Advancing drug development in myelodysplastic syndromes.
Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema, Recommendations from an Expert Panel: Part 2: Preventive and Therapeutic Options.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Advancing drug development in myelodysplastic syndromes.
Advancing drug development in myelodysplastic syndromes. Blood Adv. 2025 Mar 11; 9(5):1095-1104.
View in:
PubMed
subject areas
Clinical Trials as Topic
Humans
Myelodysplastic Syndromes